Cargando…
Investigation of some benzoquinazoline and quinazoline derivatives as novel inhibitors of HCV-NS3/4A protease: biological, molecular docking and QSAR studies
Morbidity and mortality due to hepatitis C virus (HCV) is a globe health concern. Hence, there is a persistent demand to design and optimize current HCV therapy and develop novel agents. HCV NS3/A4 protease plays an essential role in HCV life cycle and replication. Thus, HCV NS3/A4 protease inhibito...
Autores principales: | Abuelizz, Hatem A., Marzouk, Mohamed, Bakheit, Ahmed H., Al-Salahi, Rashad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056986/ https://www.ncbi.nlm.nih.gov/pubmed/35517076 http://dx.doi.org/10.1039/d0ra05604a |
Ejemplares similares
-
Benzo[g]quinazolines as antifungal against candidiasis: Screening, molecular docking, and QSAR investigations
por: Abuelizz, Hatem A., et al.
Publicado: (2023) -
Evaluation of Some Benzo[g]Quinazoline Derivatives as Antiviral Agents against Human Rotavirus Wa Strain: Biological Screening and Docking Study
por: Abuelizz, Hatem A., et al.
Publicado: (2023) -
Antiviral activity of some benzo[g]quinazolines against coxsackievirus B4: biological screening and docking study
por: Abuelizz, Hatem A., et al.
Publicado: (2023) -
Synthesis and anticancer activity of new quinazoline derivatives
por: Abuelizz, Hatem A., et al.
Publicado: (2017) -
Molecular Docking and Anticonvulsant Activity of Newly Synthesized Quinazoline Derivatives
por: Abuelizz, Hatem A., et al.
Publicado: (2017)